全文获取类型
收费全文 | 10107篇 |
免费 | 579篇 |
国内免费 | 118篇 |
专业分类
耳鼻咽喉 | 163篇 |
儿科学 | 136篇 |
妇产科学 | 117篇 |
基础医学 | 1579篇 |
口腔科学 | 228篇 |
临床医学 | 744篇 |
内科学 | 2002篇 |
皮肤病学 | 370篇 |
神经病学 | 622篇 |
特种医学 | 593篇 |
外科学 | 1490篇 |
综合类 | 50篇 |
一般理论 | 3篇 |
预防医学 | 396篇 |
眼科学 | 209篇 |
药学 | 872篇 |
1篇 | |
中国医学 | 143篇 |
肿瘤学 | 1086篇 |
出版年
2024年 | 10篇 |
2023年 | 81篇 |
2022年 | 235篇 |
2021年 | 416篇 |
2020年 | 150篇 |
2019年 | 266篇 |
2018年 | 306篇 |
2017年 | 235篇 |
2016年 | 383篇 |
2015年 | 473篇 |
2014年 | 548篇 |
2013年 | 570篇 |
2012年 | 891篇 |
2011年 | 802篇 |
2010年 | 495篇 |
2009年 | 398篇 |
2008年 | 581篇 |
2007年 | 547篇 |
2006年 | 483篇 |
2005年 | 471篇 |
2004年 | 386篇 |
2003年 | 326篇 |
2002年 | 253篇 |
2001年 | 262篇 |
2000年 | 222篇 |
1999年 | 155篇 |
1998年 | 93篇 |
1997年 | 68篇 |
1996年 | 56篇 |
1995年 | 64篇 |
1994年 | 55篇 |
1993年 | 46篇 |
1992年 | 75篇 |
1991年 | 57篇 |
1990年 | 40篇 |
1989年 | 42篇 |
1988年 | 51篇 |
1987年 | 40篇 |
1986年 | 34篇 |
1985年 | 26篇 |
1984年 | 13篇 |
1983年 | 16篇 |
1981年 | 8篇 |
1980年 | 8篇 |
1979年 | 8篇 |
1977年 | 5篇 |
1976年 | 9篇 |
1975年 | 6篇 |
1973年 | 6篇 |
1968年 | 6篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
991.
Anti-tumor activity of ex vivo expanded cytokine-induced killer cells against human hepatocellular carcinoma 总被引:3,自引:0,他引:3
Kim HM Lim J Yoon YD Ahn JM Kang JS Lee K Park SK Jeong YJ Kim JM Han G Yang KH Kim YJ Kim Y Han SB 《International immunopharmacology》2007,7(13):1793-1801
Cytokine-induced killer (CIK) cells are ex vivo expanded T cells with natural killer cell phenotypes and functions. In this study, the anti-tumor activity of CIK cells against hepatocellular carcinoma was evaluated in vitro and in vivo. In the presence of anti-CD3 antibody and IL-2 for 14 days, human peripheral blood mononuclear cell population changed to heterogeneous CIK cell population, which comprised 96% CD3(+), 3% CD3( inverted exclamation mark(c))CD56(+), 32% CD3(+)CD56(+), 11% CD4(+), 75% CD8(+), and 30% CD8(+)CD56(+). CIK cells produced significant amounts of IFN-gamma and TNF-alpha; however, produced only slight amounts of IL-2, IL-4, and IL-5. At an effector-target cell ratio of 30:1, CIK cells destroyed 33% of SNU-354 human hepatocellular carcinoma cells, which was determined by the (51)Cr-release assay. In addition, a dose of 1x10(6) CIK cells per mouse inhibited 60% of SNU-354 tumor growth in irradiated nude mice. This study suggests that CIK cells may be used as an adoptive immunotherapy for patients with hepatocellular carcinoma. 相似文献
992.
Ahn MY Jee SD Lee BM 《Journal of toxicology and environmental health. Part A》2007,70(15-16):1395-1401
In the present study, the antiobesity effects of Isaria sinclairii (I. sinclairii, a fungus cultured on silkworms) powder were investigated in obese (fa/fa) Zucker rats over 4 mo. Rats were given 5 or 10% (w/w) I. sinclairii powder (I. S.), 10% mulberry leaf powder, or 10% silkworm powder mixed with standard diet; a fifth (control) group was given standard diet alone. Dose-dependent decreases in rate of body weight gain were observed in the IS-treated groups after 2 wk of treatment. Interestingly, weights of abdominal adipose tissues surrounding the epididymides were markedly reduced by I. S., in parallel with an attenuated body weight gain. However, no significant differences were observed versus the control group in terms of urinalysis or ocular or histopathological examinations. In the serum, total cholesterol, triglyceride, bilirubin, and low-density lipoprotein (LDL) were significantly lower in the 10% I. S. group than control after 17 wk of treatment. The mulberry leaf diet (10%) significantly reduced serum bilirubin levels. Obese (fa/fa) Zucker rats displayed markedly elevated serum leptin levels (>24.6%) in the I. S. 5 and 10% groups compared with nontreated controls. Data suggest that I. sinclairii exerts an antiobesity effect in Zucker obese rats. 相似文献
993.
Jung HJ Jeon HJ Lim EJ Ahn EK Song YS Lee S Shin KH Lim CJ Park EH 《Journal of ethnopharmacology》2007,112(2):406-409
This study aimed to elucidate anti-angiogenic activity of Ulmus davidiana var. japonica that has been widely used in folk medicine. The methanol extract (UDE) of Ulmus davidiana var. japonica concentration-dependently displayed a strong inhibition in the chick chorioallantoic membrane (CAM) angiogenesis. The n-butanol fraction of UDE and subsequent 30% MeOH subfraction were identified to be most responsible for the anti-angiogenic activity. 相似文献
994.
Tirosh B Daniel-Carmi V Carmon L Paz A Lugassy G Vadai E Machlenkin A Bar-Haim E Do MS Ahn IS Fridkin M Tzehoval E Eisenbach L 《British journal of cancer》2007,97(12):1655-1663
D(b-/-)xbeta2 microglobulin (beta2m) null mice transgenic for a chimeric HLA-A2.1/D(b)-beta2m single chain (HHD mice) are an effective biological tool to evaluate the antitumour cytotoxic T-lymphocyte response of known major histocompatibility-restricted peptide tumour-associated antigens, and to screen for putative unknown novel peptides. We utilised HHD lymphocytes to identify immunodominant epitopes of colon carcinoma overexpressed genes. We screened with HHD-derived lymphocytes over 500 HLA-A2.1-restricted peptides derived from colon carcinoma overexpressed genes. This procedure culminated in the identification of seven immunogenic peptides, three of these were derived from the 'human 1-8D gene from interferon inducible gene' (1-8D). The 1-8D gene was shown to be overexpressed in fresh tumour samples. The three 1-8D peptides were both antigenic and immunogenic in the HHD mice. The peptides induce cytotoxic T lymphocytes that were able to kill a colon carcinoma cell line HCT/HHD, in vitro and retard its growth in vivo. One of the peptides shared by all the 1-8 gene family primed efficiently normal human cytotoxic T lymphocyte precursors. These results highlight the 1-8D gene and its homologues as putative immunodominant tumour-associated antigens of colon carcinoma. 相似文献
995.
BACKGROUND: Hepatic arterial infusion chemotherapy (HAIC) has often been selected as a therapeutic option for patients with advanced hepatocellular carcinoma (HCC). The objective of the current study was to evaluate the efficacy and safety of repetitive HAIC with high-dose 5-fluorouracil (5-FU) and cisplatin given for 3 days in patients with advanced HCC. METHODS: Between January 2001 and December 2004, a total of 41 patients with unresectable advanced HCC were enrolled. The patients underwent HAIC via the implantable port system with 5-FU (at a dose of 500 mg/m(2) on Days 1-3) and cisplatin (at a dose of 60 mg/m(2) on Day 2) every 4 weeks. Tumor response was assessed at the end of every 3 cycles. RESULTS: The median age of the patients was 53 years and 34 patients (82.9%) had evidence of portal vein thrombosis. In total, 230 cycles of HAIC were administered to the 41 patients, with a median of 6 cycles given (range, 1-14 cycles). Nine patients (22.0%) achieved a partial response and 14 patients (34.1%) had stable disease. The median time to disease progression and overall survival were 7.0 months and 12.0 months, respectively. The overall survival was found to be significantly longer in the successful disease control group (patients with a complete response, partial response, and stable disease) than in the disease progression group (median of 14.0 months vs 6.0 months; P < .001). Adverse reactions were tolerable and successfully managed with conservative treatment. CONCLUSIONS: HAIC with high-dose 5-FU and cisplatin given for 3 days achieved effective and safe results in patients with advanced HCC. Therefore, repetitive short-course HAIC with high-dose 5-FU and cisplatin may be useful as an alternative therapeutic option for patients with advanced HCC. 相似文献
996.
997.
998.
999.
NOS3 and MPO genes encode endothelial nitric oxide synthase and myeloperoxidase (MPO), respectively, which generate nitric oxide and reactive oxygen species. Because cigarette smoking generates reactive species, we hypothesized that NOS3 and MPO polymorphisms could influence susceptibility to breast cancer, particularly among smokers. We examined the associations between NOS3 Glu298Asp and MPO G-463A polymorphisms and breast cancer risk by cigarette smoking among post-menopausal women in the American Cancer Society's Cancer Prevention Study II Nutrition Cohort. Included in this analysis were 502 women who provided blood samples and were diagnosed with breast cancer between 1992 and 2001 and 505 cancer-free controls who were matched to the cases by age, race/ethnicity and date of blood donation. Genotyping for NOS3 and MPO was performed using TaqMan, and unconditional logistic regression was used to compute odds ratios (ORs) and 95% confidence intervals (CIs). No statistically significant relationships were found between NOS3 and MPO genotypes and breast cancer risk. When considering smoking, variant NOS3 genotypes (GT and TT) were significantly associated with reduced breast cancer risk among never smokers (OR = 0.67, 95% CI = 0.45-0.99), but were associated with higher risk among ever smokers (OR = 1.59, 95% CI = 1.05-2.41) and 2-fold increase in risk for those who smoked >10 cigarettes per day (OR = 2.19, 95% CI = 1.21-3.97). NOS3 genotypes appeared to be associated with risk of post-menopausal breast cancer among smokers, supporting the hypothesis that subgroups of women based upon genetic profiles may be at higher risk of breast cancer when exposed to tobacco smoke. 相似文献
1000.
Lee SA Lee KM Park SK Choi JY Kim B Nam J Yoo KY Noh DY Ahn SH Kang D 《Breast cancer research and treatment》2007,103(1):71-76
To evaluate the relationship of genetic polymorphism in XRCC3 Thr241Met and the risk of breast cancer, a hospital-based case-control study was conducted in Korea. Histologically confirmed breast
cancer cases (n = 574) and controls (n = 502) with no present or previous history of cancer were recruited from several teaching hospitals in Seoul during 1995–2001.
Information on demographic characteristics and other information were collected by interviewed questionnaire. Genetic polymorphisms
of XRCC3 Thr241Met (C > T) was determined by single base extention assay. The frequency of Thr/Thr, Thr/Met, and Met/Met genotype were 89.4,
10.4, 0.2% in cases and 92.3, 7.7, 0.0% in controls, respectively. Genotype distribution in controls fit well to the Hardy–Weinberg
equilibrium (P = 0.74). XRCC3 codon 241 Thr/Met or Met/Met genotype moderately increased the risk of breast cancer (OR = 1.4, 95% CI: 0.87–2.33), but not
significant in this study. In the results of meta-analysis using twelve reports, however, Thr/Met or Met/Met genotype increased
the risk of breast cancer (OR = 1.08, 95%CI: 1.00–1.17). In conclusion, although the genetic polymorphism of XRCC3 Thr241Met was unlikely to have a substantial overall association in Korean women, the meta-analysis of studies, including ours,
provided that Thr/Met and Met/Met was weakly increased the risk of breast cancer compare to Thr/Thr genotype. 相似文献